Cargando…

Electrical cardioversion for early recurrences post pulmonary vein isolation

BACKGROUND: To study the association between timing and success of electrical cardioversion (ECV) for the treatment of early recurrences (ERs) of atrial fibrillation post pulmonary vein isolation (PVI) on long-term rhythm outcome. METHODS: Data of 133 patients ablated for paroxysmal or persistent at...

Descripción completa

Detalles Bibliográficos
Autores principales: von Olshausen, Gesa, Paul-Nordin, Astrid, Tapanainen, Jari, Jensen-Urstad, Mats, Bastani, Hamid, Saluveer, Ott, Bourke, Tara, Drca, Nikola, Kennebäck, Göran, Saygi, Serkan, Turkmen, Yusuf, Insulander, Per, Braunschweig, Frieder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066117/
https://www.ncbi.nlm.nih.gov/pubmed/36085243
http://dx.doi.org/10.1007/s10840-022-01368-w
_version_ 1785018228109475840
author von Olshausen, Gesa
Paul-Nordin, Astrid
Tapanainen, Jari
Jensen-Urstad, Mats
Bastani, Hamid
Saluveer, Ott
Bourke, Tara
Drca, Nikola
Kennebäck, Göran
Saygi, Serkan
Turkmen, Yusuf
Insulander, Per
Braunschweig, Frieder
author_facet von Olshausen, Gesa
Paul-Nordin, Astrid
Tapanainen, Jari
Jensen-Urstad, Mats
Bastani, Hamid
Saluveer, Ott
Bourke, Tara
Drca, Nikola
Kennebäck, Göran
Saygi, Serkan
Turkmen, Yusuf
Insulander, Per
Braunschweig, Frieder
author_sort von Olshausen, Gesa
collection PubMed
description BACKGROUND: To study the association between timing and success of electrical cardioversion (ECV) for the treatment of early recurrences (ERs) of atrial fibrillation post pulmonary vein isolation (PVI) on long-term rhythm outcome. METHODS: Data of 133 patients ablated for paroxysmal or persistent atrial fibrillation receiving ECV for ERs, i.e., atrial tachyarrhythmia recurrences within 90 days post ablation were analyzed. During 1-year follow-up, patients were screened for late recurrences (LRs), i.e., recurrences after the blanking period. RESULTS: In 114 patients (85.7%), ECV was successful compared to 19 patients (14.3%) with failed ECV. A higher body mass index (odds ratio (OR) 1.19 (95% CI 1.02–1.39), p = 0.029), a lower left ventricular ejection fraction (OR 1.07 (95% CI 0.99–1.15), p = 0.079), and performance of ECV > 7 days from ER onset (OR 2.99 (95% CI 1.01–8.87), p = 0.048) remained independently associated with ECV failure. During 1-year follow-up, the rate of LR was significantly higher among patients with failed ECV as compared to patients with successful ECV (hazard ratio (HR) 3.00 (95% CI, 1.79–5.03), p < 0.001). Patients with ECV performed > 7 days from ER onset had a significantly higher risk of developing LR as compared to patients with ECV performed within ≤ 7 days from ER onset (HR 1.73 (95% CI 1.15–2.62), p = 0.009). Performance of ECV > 7 days from ER onset (HR 1.76 (95% CI 1.16–2.67), p = 0.008) and failed ECV (HR 3.32 (95% CI 1.96–5.64), p < 0.001) remained independently associated with LR. CONCLUSIONS: A failed ECV and performance of ECV > 7 days from ER onset were independently associated with LR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10840-022-01368-w.
format Online
Article
Text
id pubmed-10066117
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100661172023-04-02 Electrical cardioversion for early recurrences post pulmonary vein isolation von Olshausen, Gesa Paul-Nordin, Astrid Tapanainen, Jari Jensen-Urstad, Mats Bastani, Hamid Saluveer, Ott Bourke, Tara Drca, Nikola Kennebäck, Göran Saygi, Serkan Turkmen, Yusuf Insulander, Per Braunschweig, Frieder J Interv Card Electrophysiol Article BACKGROUND: To study the association between timing and success of electrical cardioversion (ECV) for the treatment of early recurrences (ERs) of atrial fibrillation post pulmonary vein isolation (PVI) on long-term rhythm outcome. METHODS: Data of 133 patients ablated for paroxysmal or persistent atrial fibrillation receiving ECV for ERs, i.e., atrial tachyarrhythmia recurrences within 90 days post ablation were analyzed. During 1-year follow-up, patients were screened for late recurrences (LRs), i.e., recurrences after the blanking period. RESULTS: In 114 patients (85.7%), ECV was successful compared to 19 patients (14.3%) with failed ECV. A higher body mass index (odds ratio (OR) 1.19 (95% CI 1.02–1.39), p = 0.029), a lower left ventricular ejection fraction (OR 1.07 (95% CI 0.99–1.15), p = 0.079), and performance of ECV > 7 days from ER onset (OR 2.99 (95% CI 1.01–8.87), p = 0.048) remained independently associated with ECV failure. During 1-year follow-up, the rate of LR was significantly higher among patients with failed ECV as compared to patients with successful ECV (hazard ratio (HR) 3.00 (95% CI, 1.79–5.03), p < 0.001). Patients with ECV performed > 7 days from ER onset had a significantly higher risk of developing LR as compared to patients with ECV performed within ≤ 7 days from ER onset (HR 1.73 (95% CI 1.15–2.62), p = 0.009). Performance of ECV > 7 days from ER onset (HR 1.76 (95% CI 1.16–2.67), p = 0.008) and failed ECV (HR 3.32 (95% CI 1.96–5.64), p < 0.001) remained independently associated with LR. CONCLUSIONS: A failed ECV and performance of ECV > 7 days from ER onset were independently associated with LR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10840-022-01368-w. Springer US 2022-09-09 2023 /pmc/articles/PMC10066117/ /pubmed/36085243 http://dx.doi.org/10.1007/s10840-022-01368-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
von Olshausen, Gesa
Paul-Nordin, Astrid
Tapanainen, Jari
Jensen-Urstad, Mats
Bastani, Hamid
Saluveer, Ott
Bourke, Tara
Drca, Nikola
Kennebäck, Göran
Saygi, Serkan
Turkmen, Yusuf
Insulander, Per
Braunschweig, Frieder
Electrical cardioversion for early recurrences post pulmonary vein isolation
title Electrical cardioversion for early recurrences post pulmonary vein isolation
title_full Electrical cardioversion for early recurrences post pulmonary vein isolation
title_fullStr Electrical cardioversion for early recurrences post pulmonary vein isolation
title_full_unstemmed Electrical cardioversion for early recurrences post pulmonary vein isolation
title_short Electrical cardioversion for early recurrences post pulmonary vein isolation
title_sort electrical cardioversion for early recurrences post pulmonary vein isolation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066117/
https://www.ncbi.nlm.nih.gov/pubmed/36085243
http://dx.doi.org/10.1007/s10840-022-01368-w
work_keys_str_mv AT vonolshausengesa electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT paulnordinastrid electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT tapanainenjari electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT jensenurstadmats electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT bastanihamid electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT saluveerott electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT bourketara electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT drcanikola electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT kennebackgoran electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT saygiserkan electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT turkmenyusuf electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT insulanderper electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation
AT braunschweigfrieder electricalcardioversionforearlyrecurrencespostpulmonaryveinisolation